Ablation Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Ablation Equipment Pipeline Market Report Overview

An Ablation Equipment is a device used to surgically remove a body tissue. The Ablation Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        The US

·        Europe

·        Canada

·        China

·        Australia

Key Regulatory Paths ·        510(k)

·        CE

·        TGA

·        MDL

·        NMPA

Leading Companies ·        AngioDynamics Inc

·        Aqua Medical Inc

·        Asensus Surgical Inc

·        Avenda Health Inc

·        Baird Medical Investment Holdings Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Ablation Equipment Pipeline Market Segmentation by Territories

A few of the key territories for Ablation Equipment pipeline products are the US, Europe, Canada, China, and Australia among others. As of December 2023, the US accounted for the highest number of pipeline products.

Ablation Equipment Pipeline Market Analysis by Territories, 2023 (%)

Ablation Equipment Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Ablation Equipment Pipeline Market

Download a Free Report Sample

Ablation Equipment Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Ablation Equipment pipeline market are 510(k), CE, TGA, MDL, and NMPA among others. As of December 2023, 510(k) was the most followed pathway for pipeline products in the market.

Ablation Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Ablation Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Ablation Equipment Pipeline Market

Download a Free Report Sample

Ablation Equipment Pipeline Market – Competitive Landscape

A few of the key companies associated with the Ablation Equipment pipeline market are AngioDynamics Inc., Aqua Medical Inc., Asensus Surgical Inc., Avenda Health Inc., and Baird Medical Investment Holdings Ltd, among others.

AngioDynamics Inc: AngioDynamics Inc. is headquartered in Latham, New York, the US. It designs, manufactures, and markets minimal invasive and image-guided therapeutics and diagnostic devices. Vascular products, radiofrequency ablation and NanoKnife systems, thrombolysis, and embolization, besides venous products, and renal therapy products, are a few of its portfolio products. The company’s products find application in interventional radiology, interventional cardiology, and minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. In the US, the company sells its products through a direct sales force while a network of distributors handles its sales in regions such as Europe, Asia, Latin America, and others.

Ablation Equipment Pipeline Market Analysis by Companies, 2023

Ablation Equipment Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Ablation Equipment Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Ablation Equipment Pipeline Market Territories Outlook

  • The US
  • Europe
  • Canada
  • China
  • Australia

Ablation Equipment Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • TGA
  • MDL
  • NMPA

Scope

This report provides:

  • An extensive coverage of the Ablation Equipment under development.
  • An exhaustive list of major pipeline products and their details, including product descriptions, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Ablation Equipment and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Ablation Equipment under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

AngioDynamics Inc
Aqua Medical Inc
Asensus Surgical Inc
Avenda Health Inc
Baird Medical Investment Holdings Ltd
Betters Medical Investment Holdings Ltd
Brattea
Broncus Medical Inc
Corveus Medical Inc
Covidien LLC
Covidien Ltd
CPSI Biotech
Creo Medical Ltd
Elesta srl
Endowave Ltd
Eximo Medical Ltd
ExpandoHeat LLC
Forerunner Medical (Shanghai) Co Ltd
Fractyl Health Inc
Francis Medical Inc
Galvanize Therapeutics Inc
Guangdong Hygeia Medical Devices Manufacturing Co Ltd
Harmonic Medical Inc
HEPTA Medical SASU
Hospital for Special Surgery
Ictero Medical Inc
Integra LifeSciences Holdings Corp
Intratherm LLC (Inactive)
I-Vasc Srl
Lepu Scientech Medical Technology (Shanghai) Co Ltd
Lukasiewicz Research Network
Massachusetts Institute of Technology
Memorial Sloan Kettering Cancer Center
Morair Medtech LLC
NeuroOne Medical Technologies Corp
ProstaCare Pty Ltd
Pulse Biosciences Inc
Sabanci University Nanotechnology Research and Application Center
Shanghai Hantong Medical Technology Co Ltd
Shenzhen Maiwei Medical Technology Co Ltd
Sinovation (Beijing) Medical Technology Co Ltd
Southern Illinois University Carbondale
Symple Surgical Inc
Thermedical Inc
University of California San Francisco
University of Georgia
University of Texas at Austin
University of Wisconsin-Stout
Uptake Medical Technology Inc
Washington University in St. Louis

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 12

2 Introduction 13

2.1 Ablation Equipments Overview 13

3 Products under Development 14

3.1 Ablation Equipments – Pipeline Products by Stage of Development 14

3.2 Ablation Equipments – Pipeline Products by Territory 15

3.3 Ablation Equipments – Pipeline Products by Regulatory Path 16

3.4 Ablation Equipments – Pipeline Products by Estimated Approval Date 17

3.5 Ablation Equipments – Ongoing Clinical Trials 18

4 Ablation Equipments – Pipeline Products under Development by Companies 19

4.1 Ablation Equipments Companies – Pipeline Products by Stage of Development 19

4.2 Ablation Equipments – Pipeline Products by Stage of Development 21

5 Ablation Equipments Companies and Product Overview 24

5.1 AngioDynamics Inc Company Overview 24

5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.2 Aqua Medical Inc Company Overview 28

5.2.1 Aqua Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.3 Asensus Surgical Inc Company Overview 31

5.3.1 Asensus Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.4 Avenda Health Inc Company Overview 32

5.4.1 Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.5 Baird Medical Investment Holdings Ltd Company Overview 35

5.5.1 Baird Medical Investment Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

5.6 Betters Medical Investment Holdings Ltd Company Overview 37

5.6.1 Betters Medical Investment Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.7 Brattea Company Overview 45

5.7.1 Brattea Pipeline Products & Ongoing Clinical Trials Overview 45

5.8 Broncus Medical Inc Company Overview 46

5.8.1 Broncus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.9 Corveus Medical Inc Company Overview 50

5.9.1 Corveus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.10 Covidien LLC Company Overview 51

5.10.1 Covidien LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.11 Covidien Ltd Company Overview 52

5.11.1 Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.12 CPSI Biotech Company Overview 53

5.12.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 53

5.13 Creo Medical Ltd Company Overview 55

5.13.1 Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

5.14 Elesta srl Company Overview 56

5.14.1 Elesta srl Pipeline Products & Ongoing Clinical Trials Overview 56

5.15 Endowave Ltd Company Overview 60

5.15.1 Endowave Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.16 Eximo Medical Ltd Company Overview 61

5.16.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

5.17 ExpandoHeat LLC Company Overview 62

5.17.1 ExpandoHeat LLC Pipeline Products & Ongoing Clinical Trials Overview 62

5.18 Forerunner Medical (Shanghai) Co Ltd Company Overview 63

5.18.1 Forerunner Medical (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.19 Fractyl Health Inc Company Overview 67

5.19.1 Fractyl Health Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.20 Francis Medical Inc Company Overview 70

5.20.1 Francis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.21 Galvanize Therapeutics Inc Company Overview 73

5.21.1 Galvanize Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.22 Guangdong Hygeia Medical Devices Manufacturing Co Ltd Company Overview 78

5.22.1 Guangdong Hygeia Medical Devices Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

5.23 Harmonic Medical Inc Company Overview 79

5.23.1 Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.24 HEPTA Medical SASU Company Overview 82

5.24.1 HEPTA Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 82

5.25 Hospital for Special Surgery Company Overview 83

5.25.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 83

5.26 Ictero Medical Inc Company Overview 84

5.26.1 Ictero Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.27 Integra LifeSciences Holdings Corp Company Overview 85

5.27.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 85

5.28 Intratherm LLC (Inactive) Company Overview 87

5.28.1 Intratherm LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 87

5.29 I-Vasc Srl Company Overview 88

5.29.1 I-Vasc Srl Pipeline Products & Ongoing Clinical Trials Overview 88

5.30 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview 91

5.30.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.31 Lukasiewicz Research Network Company Overview 92

5.31.1 Lukasiewicz Research Network Pipeline Products & Ongoing Clinical Trials Overview 92

5.32 Massachusetts Institute of Technology Company Overview 93

5.32.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 93

5.33 Memorial Sloan Kettering Cancer Center Company Overview 94

5.33.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 94

5.34 Morair Medtech LLC Company Overview 96

5.34.1 Morair Medtech LLC Pipeline Products & Ongoing Clinical Trials Overview 96

5.35 NeuroOne Medical Technologies Corp Company Overview 99

5.35.1 NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview 99

5.36 ProstaCare Pty Ltd Company Overview 101

5.36.1 ProstaCare Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

5.37 Pulse Biosciences Inc Company Overview 105

5.37.1 Pulse Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.38 Sabanci University Nanotechnology Research and Application Center Company Overview 106

5.38.1 Sabanci University Nanotechnology Research and Application Center Pipeline Products & Ongoing Clinical Trials Overview 106

5.39 Shanghai Hantong Medical Technology Co Ltd Company Overview 107

5.39.1 Shanghai Hantong Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 107

5.40 Shenzhen Maiwei Medical Technology Co Ltd Company Overview 110

5.40.1 Shenzhen Maiwei Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

5.41 Sinovation (Beijing) Medical Technology Co Ltd Company Overview 112

5.41.1 Sinovation (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

5.42 Southern Illinois University Carbondale Company Overview 113

5.42.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 113

5.43 Symple Surgical Inc Company Overview 114

5.43.1 Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 114

5.44 Thermedical Inc Company Overview 115

5.44.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 115

5.45 University of California San Francisco Company Overview 116

5.45.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 116

5.46 University of Georgia Company Overview 117

5.46.1 University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 117

5.47 University of Texas at Austin Company Overview 118

5.47.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 118

5.48 University of Wisconsin-Stout Company Overview 119

5.48.1 University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 119

5.49 Uptake Medical Technology Inc Company Overview 120

5.49.1 Uptake Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.50 Washington University in St. Louis Company Overview 124

5.50.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 124

6 Ablation Equipments- Recent Developments 125

6.1 Nov 23, 2023: BaiDe (Suzhou) Medical Receives 510(K) Clearance For Microwave Ablation System (BD-GT) 125

6.2 Nov 22, 2023: Baird Medical wins FDA clearance for microwave ablation system 125

6.3 Nov 10, 2023: HC Surgical Specialists Announces Change of Registered Office Address 126

6.4 Nov 07, 2023: NeuroOne Provides Progress Update on FDA 510 (k) Submission for OneRF Ablation System 126

6.5 Nov 06, 2023: Galvanize Therapeutics Announces Promising Data on the Aliya Pulsed Electric Field (PEF) System in Early-Stage Non-Small Cell Lung Cancer 126

6.6 Oct 25, 2023: HSS Appoints New Leadership in Neurology and Anesthesia 127

6.7 Oct 09, 2023: Stryker to Host Investor Day 128

6.8 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 128

6.9 Oct 03, 2023: Olympus Names Dr. John de Csepel as Chief Medical Officer 128

6.10 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023 129

6.11 Sep 28, 2023: Fractyl Health to Present Pioneering Data on Revita and Rejuva Programs at the European Association for the Study of Diabetes (EASD) 2023 Scientific Congress 129

6.12 Sep 21, 2023: Galvanize Therapeutics commences Aliya PEF System trial 130

6.13 Sep 21, 2023: Relievant Medsystems Introduces Intracept Simulator System Powered by Medability for Improved and Expanded Physician Training Opportunities 130

6.14 Sep 18, 2023: Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients 131

6.15 Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board 131

6.16 Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business 132

6.17 Sep 14, 2023: Smith & Nephew Announces Board Changes 132

6.18 Sep 12, 2023: Relievant Medsystems Announces Pooled Analysis Demonstrating the Intracept Procedure Significantly Reduces Low Back Pain-related Healthcare Utilization 133

6.19 Sep 11, 2023: HC Surgical Specialists Notice of Annual General Meeting 133

6.20 Sep 05, 2023: Baird Medical’s Single-Use Sterile Biopsy Needle Receives Approval From Jiangsu Medical Products Administration in China 135

6.21 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 136

6.22 Aug 10, 2023: Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation 136

6.23 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 136

6.24 Aug 01, 2023: Fractyl Health Announces Clinical Update on Revita Real World Registry in Germany and Launch of Revita+ Telehealth Program Combining Behavioral Recommendations with Revita Treatment for Type 2 Diabetes 137

6.25 Aug 01, 2023: Francis Medical Receives U.S. FDA Breakthrough Device Designation for Vanquish Minimally Invasive Prostate Cancer Therapy 137

6.26 Jul 20, 2023: Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure 138

6.27 Jul 19, 2023: NMPA green lights Class III registered microwave ablation needle 139

6.28 Jul 12, 2023: ArthroCare Receives an Additional 510(k) Clearance for Werewolf Coblation System 139

6.29 Jul 12, 2023: ArthroCare Receives an Additional 510(k) Clearance for Werewolf+ Coblation System 139

6.30 Jul 11, 2023: Compal Electronics Receives 510(k) Clearance for AblatePal RF Ablation System 140

6.31 Jun 26, 2023: Fractyl Health Reports Durable Improvement in Glucose Control, Weight Loss, and Insulin Reduction in T2D Patients Using Revita in Open Label Phase of Revitalize 1 Pivotal Study at the American Diabetes Association 83rd Scientific Sessions 140

6.32 Jun 20, 2023: Relievant Medsystems Announces Favorable Coverage Policy From Cigna Healthcare for the Intracept Procedure 141

6.33 Jun 15, 2023: Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients 141

6.34 Jun 13, 2023: HSS Appoints Mary E. Cassai, RN to Executive Vice President, Chief Operating Officer 142

6.35 Jun 12, 2023: NeuroOne Submits 510(k) Application to FDA for OneRF Ablation System 143

6.36 May 12, 2023: Olympus announces consolidated financial results for the fiscal year ended March 31, 2023 144

6.37 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 144

6.38 May 09, 2023: Relievant Medsystems announces more than 10,000 patients treated with the Intracept procedure for Vertebrogenic Low Back Pain 144

6.39 May 02, 2023: Fractyl Health to present Scientific updates on Revita and Rejuva Programs at Upcoming Medical Congresses 145

6.40 Apr 28, 2023: FDA grants breakthrough device status to Innoblative’s SIRA 145

6.41 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 146

6.42 Apr 26, 2023: HC Surgical Specialists Announces Appointment of Chief Nursing Officer 149

6.43 Apr 24, 2023: Fractyl Health announces the Initiation of a global registry study of the Revita System in patients with inadequately controlled Type 2 Diabetes (T2D) 149

6.44 Apr 17, 2023: Rafaelo meets expectations of a minimally invasive technique 150

6.45 Apr 12, 2023: Medtronic has a layoff in California 150

6.46 Apr 10, 2023: Compal Electronics launches new RFA system AblatePal 150

6.47 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 150

6.48 Mar 30, 2023: Relievant Medsystems receives 2023 Gallup Exceptional Workplace Award 151

6.49 Mar 30, 2023: AngioDynamics announces exciting new partnership with Minimax Medical 151

6.50 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 151

6.51 Mar 16, 2023: NeuroOne successfully completes initial animal implant of novel thin film paddle lead for spinal cord stimulation 152

6.52 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 152

6.53 Mar 15, 2023: Mima-Pro Scientific receives 510(k) clearance for SurBlate Ablation System 152

6.54 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions 153

6.55 Mar 07, 2023: New interventional oncology data show potential for Aliya pulsed electric field (PEF) system in treatment of solid tumors 153

6.56 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 154

6.57 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 154

6.58 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 154

6.59 Feb 15, 2023: World Leader In Musculoskeletal Health HSS Announces Douglas E. Padgett, MD to become Next Surgeon-in-Chief and Medical Director 155

6.60 Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Full-year Forecasts for Fiscal 2023 156

6.61 Feb 07, 2023: Fractyl Health announces commercial availability of Revita in Germany and successful first procedure at 25th Dusseldorf International Endoscopy Symposium 157

6.62 Feb 06, 2023: Hospital for Special Surgery Announces Rightmove Appoints Marcus Osborne As Ceo 157

6.63 Jan 31, 2023: Fractyl Health provides clinical update on 24-Week data from open label REVITA-T2Di Cohort 158

6.64 Jan 27, 2023: Hospital for Special Surgery Announces Leadership Change 160

6.65 Jan 13, 2023: HSS Florida Continues to Grow With Appointment of Tara M. McCoy As CEO 161

6.66 Jan 05, 2023: Relievant Medsystems announces highest quality of evidence ranking for basivertebral nerve ablation in ASPN back guideline for interventional low back pain treatments 162

6.67 Dec 20, 2022: AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference 162

6.68 Dec 06, 2022: NeuroOne successfully completes feasibility study with its OneRF ablation system 162

7 Appendix 164

7.1 Methodology 164

7.2 About GlobalData 167

7.3 Contact Us 167

7.4 Disclaimer 167

Table

Ablation Equipments – Pipeline Products by Stage of Development 14

Ablation Equipments – Pipeline Products by Territory 15

Ablation Equipments – Pipeline Products by Regulatory Path 16

Ablation Equipments – Pipeline Products by Estimated Approval Date 17

Ablation Equipments – Ongoing Clinical Trials 18

Ablation Equipments Companies – Pipeline Products by Stage of Development 19

Ablation Equipments – Pipeline Products by Stage of Development 21

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 24

NanoKnife 3.0 System – Liver Cancer – Product Status 24

NanoKnife 3.0 System – Liver Cancer – Product Description 25

NanoKnife 3.0 System – Pancreatic Cancer – Product Status 25

NanoKnife 3.0 System – Pancreatic Cancer – Product Description 25

NanoKnife 3.0 System – Prostate Cancer – Product Status 26

NanoKnife 3.0 System – Prostate Cancer – Product Description 26

POWERWAVE – Product Status 26

POWERWAVE – Product Description 27

Aqua Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Radio Frequency Vapor Ablation (RFVA) System – Precancerous Pancreatic Cysts – Product Status 28

Radio Frequency Vapor Ablation (RFVA) System – Precancerous Pancreatic Cysts – Product Description 28

Radio Frequency Vapor Ablation (RFVA) System – Pulmonary Tissue Ablation – Product Status 29

Radio Frequency Vapor Ablation (RFVA) System – Pulmonary Tissue Ablation – Product Description 29

Radio Frequency Vapor Ablation (RFVA) System – Type 2 Diabetes – Product Status 29

Radio Frequency Vapor Ablation (RFVA) System – Type 2 Diabetes – Product Description 30

Asensus Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Barrett’s Excision Device – Product Status 31

Barrett’s Excision Device – Product Description 31

Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview 32

FocalPoint Ablation System – Product Status 32

FocalPoint Ablation System – Product Description 32

Avenda Health Inc – Ongoing Clinical Trials Overview 33

FocalPoint Ablation System – Office-based Focal Laser Ablation of Prostate Cancer: An Early Feasibility Study Using MRI/US Image Fusion for Guidance 34

Baird Medical Investment Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

Disposable Microwave Ablation Needle – Product Status 35

Disposable Microwave Ablation Needle – Product Description 35

Microwave Ablation System – Product Status 36

Microwave Ablation System – Product Description 36

Betters Medical Investment Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Endoscope-Guided Puncture MWA Needle – Product Status 37

Endoscope-Guided Puncture MWA Needle – Product Description 38

Microwave Ablation Catheter – Product Status 38

Microwave Ablation Catheter – Product Description 38

Microwave Ablation Therapeutic Apparatus – Bone Tumours – Product Status 39

Microwave Ablation Therapeutic Apparatus – Bone Tumours – Product Description 39

Microwave Ablation Therapeutic Apparatus – Breast Lump – Product Status 39

Microwave Ablation Therapeutic Apparatus – Breast Lump – Product Description 40

Microwave Ablation Therapeutic Apparatus – Pulmonary Nodule – Product Status 40

Microwave Ablation Therapeutic Apparatus – Pulmonary Nodule – Product Description 40

Microwave Ablation Therapeutic Apparatus – Uterine Fibroids – Product Status 41

Microwave Ablation Therapeutic Apparatus – Uterine Fibroids – Product Description 41

Microwave Ablation Therapeutic Apparatus – Varicose Veins – Product Status 41

Microwave Ablation Therapeutic Apparatus – Varicose Veins – Product Description 42

MTI-5FT 915 MHz MWA Therapeutic Apparatus – Product Status 42

MTI-5FT 915 MHz MWA Therapeutic Apparatus – Product Description 42

MTI-5GT Four-Source MWA Therapeutic Apparatus – Product Status 43

MTI-5GT Four-Source MWA Therapeutic Apparatus – Product Description 43

MWA-Ultrasound Integrated Therapeutic Apparatus – Product Status 43

MWA-Ultrasound Integrated Therapeutic Apparatus – Product Description 44

Brattea Pipeline Products & Ongoing Clinical Trials Overview 45

Percutaneous Intravascular Radiofrequency Nerve Ablation Device – Product Status 45

Percutaneous Intravascular Radiofrequency Nerve Ablation Device – Product Description 45

Broncus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Intervapor System – Lung Cancer – Product Status 46

Intervapor System – Lung Cancer – Product Description 46

Percutaneous RFA Probe – Product Status 47

Percutaneous RFA Probe – Product Description 47

RF-SEG Generator + RF-iCon Ablation Catheter (RF-II) – Product Status 47

RF-SEG Generator + RF-iCon Ablation Catheter (RF-II) – Product Description 47

Broncus Medical Inc – Ongoing Clinical Trials Overview 48

RF-SEG Generator + RF-iCon Ablation Catheter (RF-II) – A Multicenter, Single Group Target Value Clinical Study to Evaluate Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors 49

Corveus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Nerve Ablation Catheter – Product Status 50

Nerve Ablation Catheter – Product Description 50

Covidien LLC Pipeline Products & Ongoing Clinical Trials Overview 51

Emprint Ablation Catheter Kit – Product Status 51

Emprint Ablation Catheter Kit – Product Description 51

Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Evident MWA System – Lung Tumors – Product Status 52

Evident MWA System – Lung Tumors – Product Description 52

CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 53

Pressurized Sub-Cooled Nitrogen System – Product Status 53

Pressurized Sub-Cooled Nitrogen System – Product Description 53

Super-Critical Nitrogen (SCN) Cryoablation Device – Product Status 54

Super-Critical Nitrogen (SCN) Cryoablation Device – Product Description 54

Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

Flexible Ablation System – Product Status 55

Flexible Ablation System – Product Description 55

Elesta srl Pipeline Products & Ongoing Clinical Trials Overview 56

EchoLaser EVO SoracteLite – Product Status 56

EchoLaser EVO SoracteLite – Product Description 56

EchoLaser X4 – Product Status 57

EchoLaser X4 – Product Description 57

Elesta srl – Ongoing Clinical Trials Overview 58

EchoLaser EVO SoracteLite – Soractelite Transperineal Laser Ablation for Benign Prostatic Hyperplasia with Bladder Outlet Obstruction 59

Endowave Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Microwave Ablation Catheter – Lung Cancer – Product Status 60

Microwave Ablation Catheter – Lung Cancer – Product Description 60

Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

AURYON Atherectomy System – Gastrointestinal Procedures – Product Status 61

AURYON Atherectomy System – Gastrointestinal Procedures – Product Description 61

ExpandoHeat LLC Pipeline Products & Ongoing Clinical Trials Overview 62

Catheter Device – Tissue Ablation – Product Status 62

Catheter Device – Tissue Ablation – Product Description 62

Forerunner Medical (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

Radio Frequency Ablation Device – Bone Tumors – Product Status 63

Radio Frequency Ablation Device – Bone Tumors – Product Description 63

Radio Frequency Ablation Device – Breast Nodules – Product Status 64

Radio Frequency Ablation Device – Breast Nodules – Product Description 64

Radio Frequency Ablation Device – Hemorrhoid – Product Status 64

Radio Frequency Ablation Device – Hemorrhoid – Product Description 65

Radio Frequency Ablation Device – Pulmonary Nodules – Product Status 65

Radio Frequency Ablation Device – Pulmonary Nodules – Product Description 65

Radio Frequency Ablation Device – Uterine Fibroids – Product Status 66

Radio Frequency Ablation Device – Uterine Fibroids – Product Description 66

Fractyl Health Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Revita DMR System – Product Status 67

Revita DMR System – Product Description 67

Fractyl Health Inc – Ongoing Clinical Trials Overview 68

Revita DMR System – A Prospective, Randomized, Double-blind, Sham-controlled, Multi-center Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita System in Subjects with Type 2 Diabetes on Insulin Therapy 69

Revita DMR System – A Randomized Double-blind Sham-controlled Trial to Evaluate Efficacy+Safety of Revita Duodenal Mucosal Resurfacing (DMR) Treatment Paradigm+Retreatment in Patients With Type 2 Diabetes Using Non-insulin Glucose Lowering Medications (REMIND) 69

Revita DMR System – Pivotal Study to Evaluate the Efficacy of Revita DMR System in Patients with Type 2 Diabetes (T2D): Revitalize-2 69

Francis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Vanquish System – Prostate Cancer – Product Status 70

Vanquish System – Prostate Cancer – Product Description 70

Francis Medical Inc – Ongoing Clinical Trials Overview 71

Vanquish System – Prostate Cancer – Prospective, Multicenter, Single-Arm Study of Vanquish Water Vapor Ablation for Prostate Cancer 72

Galvanize Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Aliya PEF System – Breast Cancer – Product Status 73

Aliya PEF System – Breast Cancer – Product Description 73

Aliya PEF System – Hepatocellular Carcinoma – Product Status 74

Aliya PEF System – Hepatocellular Carcinoma – Product Description 74

Aliya PEF System – NSCLC – Product Status 74

Aliya PEF System – NSCLC – Product Description 75

Aliya PEF System – Renal Cell Carcinoma – Product Status 75

Aliya PEF System – Renal Cell Carcinoma – Product Description 75

Galvanize Therapeutics Inc – Ongoing Clinical Trials Overview 76

Aliya PEF System – NSCLC – A Clinical Study of Aliya Pulsed Electric Fields (PEF) Delivered Prior to Standard of Care Treatment for Advanced Cancer 77

Aliya PEF System – NSCLC – Safety and Clinical Efficacy Evaluation of Pulsed Electric Field Therapy in Patients with Late-stage Non-small Cell Lung Cancer 77

Aliya PEF System – NSCLC – The Galvanize Therapeutics Early Stage, Non-Small Cell Lung Cancer, Treat and Resect Study 77

Guangdong Hygeia Medical Devices Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

Cold And Heat Ablation System – Product Status 78

Cold And Heat Ablation System – Product Description 78

Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Symphony MRI guided High Intensity Focused Ultrasound – Leiomyomas – Product Status 79

Symphony MRI guided High Intensity Focused Ultrasound – Leiomyomas – Product Description 79

Harmonic Medical Inc – Ongoing Clinical Trials Overview 80

Symphony MRI guided High Intensity Focused Ultrasound – Leiomyomas – MRI-guided High Intensity Focused Ultrasound Ablation of Leiomyomas. Single Arm, Feasibility Study Using the Symphony – MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas 81

HEPTA Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 82

Ablation Catheter – Lung Cancer – Product Status 82

Ablation Catheter – Lung Cancer – Product Description 82

Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 83

Radiofrequency Ablation Device – Product Status 83

Radiofrequency Ablation Device – Product Description 83

Ictero Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 84

CholeSafe System – Product Status 84

CholeSafe System – Product Description 84

Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 85

CUSA Accessories – Product Status 85

CUSA Accessories – Product Description 85

CUSA Ultrasonic Tissue Ablation System – Liver – Product Status 86

CUSA Ultrasonic Tissue Ablation System – Liver – Product Description 86

Intratherm LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 87

Conductive Interstitial Thermal Therapy (CITT) Device – Product Status 87

Conductive Interstitial Thermal Therapy (CITT) Device – Product Description 87

I-Vasc Srl Pipeline Products & Ongoing Clinical Trials Overview 88

VELEX – Product Status 88

VELEX – Product Description 88

I-Vasc Srl – Ongoing Clinical Trials Overview 89

VELEX – V.A.S.C. (Vacuum Assisted Sclerotherapy Performed by Catheter) 90

Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

Radiofrequency Ablation Device – Product Status 91

Radiofrequency Ablation Device – Product Description 91

Lukasiewicz Research Network Pipeline Products & Ongoing Clinical Trials Overview 92

Electrical Impulse Generation Device – Product Status 92

Electrical Impulse Generation Device – Product Description 92

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 93

Image Guided Endoscopic Ablation Device – Product Status 93

Image Guided Endoscopic Ablation Device – Product Description 93

Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 94

Image-Guided Ablation Device – Barrett’s Esophagus – Product Status 94

Image-Guided Ablation Device – Barrett’s Esophagus – Product Description 94

Image-Guided Ablation Device – Pancreatic And Bile Duct Cancer – Product Status 95

Image-Guided Ablation Device – Pancreatic And Bile Duct Cancer – Product Description 95

Morair Medtech LLC Pipeline Products & Ongoing Clinical Trials Overview 96

ETLA System – Product Status 96

ETLA System – Product Description 96

Morair Medtech LLC – Ongoing Clinical Trials Overview 97

ETLA System – The REDUCE Study – Safety of the Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Severe Emphysema with hyperinflation – A First in Human Study (CSP-11121) 98

NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview 99

OneRF Ablation System – Product Status 99

OneRF Ablation System – Product Description 99

Therapeutic Electrode – Brain Tissue Ablation – Product Status 100

Therapeutic Electrode – Brain Tissue Ablation – Product Description 100

ProstaCare Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

Neuflo System – Product Status 101

Neuflo System – Product Description 101

ProstaFix System – Product Status 102

ProstaFix System – Product Description 102

ProstaCare Pty Ltd – Ongoing Clinical Trials Overview 103

Neuflo System – Neuflo Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia 104

Pulse Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 105

PulseTx System – Soft Tissue Ablation – Product Status 105

PulseTx System – Soft Tissue Ablation – Product Description 105

Sabanci University Nanotechnology Research and Application Center Pipeline Products & Ongoing Clinical Trials Overview 106

Ultrasonic Cavitation Device – BPH – Product Status 106

Ultrasonic Cavitation Device – BPH – Product Description 106

Shanghai Hantong Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 107

Next-Generation Ultrasound Ablation System – Chronic Obstructive Pulmonary Disease – Product Status 107

Next-Generation Ultrasound Ablation System – Chronic Obstructive Pulmonary Disease – Product Description 107

Next-Generation Ultrasound Ablation System – Diabetes – Product Status 108

Next-Generation Ultrasound Ablation System – Diabetes – Product Description 108

Next-Generation Ultrasound Ablation System – Pulmonary Hypertension – Product Status 108

Next-Generation Ultrasound Ablation System – Pulmonary Hypertension – Product Description 109

Shenzhen Maiwei Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

Nano Knife – Product Status 110

Nano Knife – Product Description 110

Renal Artery Nerve Ablation Device – Product Status 111

Renal Artery Nerve Ablation Device – Product Description 111

Sinovation (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

MRI-Guided Intracranial Laser Ablation Device – Product Status 112

MRI-Guided Intracranial Laser Ablation Device – Product Description 112

Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 113

Thermoablation Probe – Product Status 113

Thermoablation Probe – Product Description 113

Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 114

DirectAblate Grizzly Microwave Ablation Catheter – Product Status 114

DirectAblate Grizzly Microwave Ablation Catheter – Product Description 114

Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 115

SERF Ablation System – Fibroids – Product Status 115

SERF Ablation System – Fibroids – Product Description 115

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 116

Robotic Needle Ablation Tool And Securement Device – Product Status 116

Robotic Needle Ablation Tool And Securement Device – Product Description 116

University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 117

Radiofrequency Tissue Ablation System – Product Status 117

Radiofrequency Tissue Ablation System – Product Description 117

University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 118

Plasmonic Laser Ablation Device – Product Status 118

Plasmonic Laser Ablation Device – Product Description 118

University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 119

Microwave Ablation Probe – Product Status 119

Microwave Ablation Probe – Product Description 119

Uptake Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 120

Intervapor System – Emphysema – Product Status 120

Intervapor System – Emphysema – Product Description 120

Uptake Medical Technology Inc – Ongoing Clinical Trials Overview 121

Intervapor System – Emphysema – Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation 122

Intervapor System – Emphysema – Post-Market BTVA Registry for Patients with Emphysema Treated with BTVA 122

Intervapor System – Emphysema – Post-market Registry for Patients with Emphysema Treated with BTVA in India 122

Intervapor System – Emphysema – Targeted Segmental Vapor Ablation Treatment of Emphysema with Upper Lobe Predominance: A Randomized Controlled Trial of InterVapor in France – The TARGET Trial 123

Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 124

Thermoablation Probe – Product Status 124

Thermoablation Probe – Product Description 124

Glossary 166

Figures

Ablation Equipments – Pipeline Products by Stage of Development 14

Ablation Equipments – Pipeline Products by Territory 15

Ablation Equipments – Pipeline Products by Regulatory Path 16

Ablation Equipments – Pipeline Products by Estimated Approval Date 17

Ablation Equipments – Ongoing Clinical Trials 18

Frequently asked questions

Ablation Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Ablation Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Ablation Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Ablation Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.